Anal carcinoma, version 2.2012

Featured updates to the NCCN guidelines

Al B. Benson, J. Pablo Arnoletti, Tanios Bekaii-Saab, Emily Chan, Yi Jen Chen, Michael A. Choti, Harry S. Cooper, Raza A. Dilawari, Paul F. Engstrom, Peter C. Enzinger, Marwan G. Fakih, James W. Fleshman, Charles S. Fuchs, Jean L. Grem, Lucille A. Leong, Edward Lin, Kilian Salerno May, Mary F. Mulcahy, Kate Murphy, Eric Rohren & 10 others David P. Ryan, Leonard Saltz, Sunil Sharma, David Shibata, John M. Skibber, William Small, Constantinos T. Sofocleous, Alan P. Venook, Christopher Willett, Deborah A. Freedman-Cass

Research output: Contribution to journalReview article

57 Citations (Scopus)

Abstract

The workup and management of squamous cell anal carcinoma, which represents the most common histologic form of the disease, are addressed in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Anal Carcinoma. These NCCN Guidelines Insights provide a summary of major discussion points of the 2012 NCCN Anal Carcinoma Panel meeting. In summary, the panel made 4 significant changes to the 2012 NCCN Guidelines for Anal Carcinoma: 1) local radiation therapy was added as an option for the treatment of patients with metastatic disease; 2) multifield technique is now preferred over anteroposterior-posteroanterior (AP-PA) technique for radiation delivery and the AP-PA technique is no longer recommended as the standard of care; 3) PET/CT should now be considered for radiation therapy planning; and 4) a section on risk reduction was added to the discussion section. In addition, the panel discussed the use of PET/CT for the workup of anal canal cancer and decided to maintain the recommendation that it can be considered in this setting. They also discussed the use of PET/CT for the workup of anal margin cancer and for the assessment of treatment response. They reaffirmed their recommendation that PET/CT is not appropriate in these settings.

Original languageEnglish (US)
Pages (from-to)449-454
Number of pages6
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume10
Issue number4
DOIs
StatePublished - Apr 1 2012

Fingerprint

Anus Neoplasms
Guidelines
Carcinoma
Radiotherapy
Anal Canal
Risk Reduction Behavior
Standard of Care
Practice Guidelines
Squamous Cell Carcinoma
Radiation
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

Benson, A. B., Arnoletti, J. P., Bekaii-Saab, T., Chan, E., Chen, Y. J., Choti, M. A., ... Freedman-Cass, D. A. (2012). Anal carcinoma, version 2.2012: Featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 10(4), 449-454. https://doi.org/10.6004/jnccn.2012.0046

Anal carcinoma, version 2.2012 : Featured updates to the NCCN guidelines. / Benson, Al B.; Arnoletti, J. Pablo; Bekaii-Saab, Tanios; Chan, Emily; Chen, Yi Jen; Choti, Michael A.; Cooper, Harry S.; Dilawari, Raza A.; Engstrom, Paul F.; Enzinger, Peter C.; Fakih, Marwan G.; Fleshman, James W.; Fuchs, Charles S.; Grem, Jean L.; Leong, Lucille A.; Lin, Edward; May, Kilian Salerno; Mulcahy, Mary F.; Murphy, Kate; Rohren, Eric; Ryan, David P.; Saltz, Leonard; Sharma, Sunil; Shibata, David; Skibber, John M.; Small, William; Sofocleous, Constantinos T.; Venook, Alan P.; Willett, Christopher; Freedman-Cass, Deborah A.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 10, No. 4, 01.04.2012, p. 449-454.

Research output: Contribution to journalReview article

Benson, AB, Arnoletti, JP, Bekaii-Saab, T, Chan, E, Chen, YJ, Choti, MA, Cooper, HS, Dilawari, RA, Engstrom, PF, Enzinger, PC, Fakih, MG, Fleshman, JW, Fuchs, CS, Grem, JL, Leong, LA, Lin, E, May, KS, Mulcahy, MF, Murphy, K, Rohren, E, Ryan, DP, Saltz, L, Sharma, S, Shibata, D, Skibber, JM, Small, W, Sofocleous, CT, Venook, AP, Willett, C & Freedman-Cass, DA 2012, 'Anal carcinoma, version 2.2012: Featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 10, no. 4, pp. 449-454. https://doi.org/10.6004/jnccn.2012.0046
Benson, Al B. ; Arnoletti, J. Pablo ; Bekaii-Saab, Tanios ; Chan, Emily ; Chen, Yi Jen ; Choti, Michael A. ; Cooper, Harry S. ; Dilawari, Raza A. ; Engstrom, Paul F. ; Enzinger, Peter C. ; Fakih, Marwan G. ; Fleshman, James W. ; Fuchs, Charles S. ; Grem, Jean L. ; Leong, Lucille A. ; Lin, Edward ; May, Kilian Salerno ; Mulcahy, Mary F. ; Murphy, Kate ; Rohren, Eric ; Ryan, David P. ; Saltz, Leonard ; Sharma, Sunil ; Shibata, David ; Skibber, John M. ; Small, William ; Sofocleous, Constantinos T. ; Venook, Alan P. ; Willett, Christopher ; Freedman-Cass, Deborah A. / Anal carcinoma, version 2.2012 : Featured updates to the NCCN guidelines. In: JNCCN Journal of the National Comprehensive Cancer Network. 2012 ; Vol. 10, No. 4. pp. 449-454.
@article{92976ad86ccc4749b06c015812944563,
title = "Anal carcinoma, version 2.2012: Featured updates to the NCCN guidelines",
abstract = "The workup and management of squamous cell anal carcinoma, which represents the most common histologic form of the disease, are addressed in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Anal Carcinoma. These NCCN Guidelines Insights provide a summary of major discussion points of the 2012 NCCN Anal Carcinoma Panel meeting. In summary, the panel made 4 significant changes to the 2012 NCCN Guidelines for Anal Carcinoma: 1) local radiation therapy was added as an option for the treatment of patients with metastatic disease; 2) multifield technique is now preferred over anteroposterior-posteroanterior (AP-PA) technique for radiation delivery and the AP-PA technique is no longer recommended as the standard of care; 3) PET/CT should now be considered for radiation therapy planning; and 4) a section on risk reduction was added to the discussion section. In addition, the panel discussed the use of PET/CT for the workup of anal canal cancer and decided to maintain the recommendation that it can be considered in this setting. They also discussed the use of PET/CT for the workup of anal margin cancer and for the assessment of treatment response. They reaffirmed their recommendation that PET/CT is not appropriate in these settings.",
author = "Benson, {Al B.} and Arnoletti, {J. Pablo} and Tanios Bekaii-Saab and Emily Chan and Chen, {Yi Jen} and Choti, {Michael A.} and Cooper, {Harry S.} and Dilawari, {Raza A.} and Engstrom, {Paul F.} and Enzinger, {Peter C.} and Fakih, {Marwan G.} and Fleshman, {James W.} and Fuchs, {Charles S.} and Grem, {Jean L.} and Leong, {Lucille A.} and Edward Lin and May, {Kilian Salerno} and Mulcahy, {Mary F.} and Kate Murphy and Eric Rohren and Ryan, {David P.} and Leonard Saltz and Sunil Sharma and David Shibata and Skibber, {John M.} and William Small and Sofocleous, {Constantinos T.} and Venook, {Alan P.} and Christopher Willett and Freedman-Cass, {Deborah A.}",
year = "2012",
month = "4",
day = "1",
doi = "10.6004/jnccn.2012.0046",
language = "English (US)",
volume = "10",
pages = "449--454",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "4",

}

TY - JOUR

T1 - Anal carcinoma, version 2.2012

T2 - Featured updates to the NCCN guidelines

AU - Benson, Al B.

AU - Arnoletti, J. Pablo

AU - Bekaii-Saab, Tanios

AU - Chan, Emily

AU - Chen, Yi Jen

AU - Choti, Michael A.

AU - Cooper, Harry S.

AU - Dilawari, Raza A.

AU - Engstrom, Paul F.

AU - Enzinger, Peter C.

AU - Fakih, Marwan G.

AU - Fleshman, James W.

AU - Fuchs, Charles S.

AU - Grem, Jean L.

AU - Leong, Lucille A.

AU - Lin, Edward

AU - May, Kilian Salerno

AU - Mulcahy, Mary F.

AU - Murphy, Kate

AU - Rohren, Eric

AU - Ryan, David P.

AU - Saltz, Leonard

AU - Sharma, Sunil

AU - Shibata, David

AU - Skibber, John M.

AU - Small, William

AU - Sofocleous, Constantinos T.

AU - Venook, Alan P.

AU - Willett, Christopher

AU - Freedman-Cass, Deborah A.

PY - 2012/4/1

Y1 - 2012/4/1

N2 - The workup and management of squamous cell anal carcinoma, which represents the most common histologic form of the disease, are addressed in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Anal Carcinoma. These NCCN Guidelines Insights provide a summary of major discussion points of the 2012 NCCN Anal Carcinoma Panel meeting. In summary, the panel made 4 significant changes to the 2012 NCCN Guidelines for Anal Carcinoma: 1) local radiation therapy was added as an option for the treatment of patients with metastatic disease; 2) multifield technique is now preferred over anteroposterior-posteroanterior (AP-PA) technique for radiation delivery and the AP-PA technique is no longer recommended as the standard of care; 3) PET/CT should now be considered for radiation therapy planning; and 4) a section on risk reduction was added to the discussion section. In addition, the panel discussed the use of PET/CT for the workup of anal canal cancer and decided to maintain the recommendation that it can be considered in this setting. They also discussed the use of PET/CT for the workup of anal margin cancer and for the assessment of treatment response. They reaffirmed their recommendation that PET/CT is not appropriate in these settings.

AB - The workup and management of squamous cell anal carcinoma, which represents the most common histologic form of the disease, are addressed in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Anal Carcinoma. These NCCN Guidelines Insights provide a summary of major discussion points of the 2012 NCCN Anal Carcinoma Panel meeting. In summary, the panel made 4 significant changes to the 2012 NCCN Guidelines for Anal Carcinoma: 1) local radiation therapy was added as an option for the treatment of patients with metastatic disease; 2) multifield technique is now preferred over anteroposterior-posteroanterior (AP-PA) technique for radiation delivery and the AP-PA technique is no longer recommended as the standard of care; 3) PET/CT should now be considered for radiation therapy planning; and 4) a section on risk reduction was added to the discussion section. In addition, the panel discussed the use of PET/CT for the workup of anal canal cancer and decided to maintain the recommendation that it can be considered in this setting. They also discussed the use of PET/CT for the workup of anal margin cancer and for the assessment of treatment response. They reaffirmed their recommendation that PET/CT is not appropriate in these settings.

UR - http://www.scopus.com/inward/record.url?scp=84860750960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860750960&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2012.0046

DO - 10.6004/jnccn.2012.0046

M3 - Review article

VL - 10

SP - 449

EP - 454

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 4

ER -